3 year experience of deferasirox in a small paediatric cohort of beta thalassaemia major patients

被引：0
|
作者：
Welch, J. C. [1 ]
机构：
[1] Sheffield Childrens NHS Fdn Trust, Dept Haematol, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
157
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [21] The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
    Sarah Allegra
    Jessica Cusato
    Silvia De Francia
    Filomena Longo
    Elisa Pirro
    Davide Massano
    Valeria Avataneo
    Amedeo De Nicolò
    Antonio Piga
    Antonio D’Avolio
    The Pharmacogenomics Journal, 2019, 19 : 417 - 427
  • [22] MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine
    Pepe, Alessia
    Meloni, Antonella
    Pistoia, Laura
    Cuccia, Liana
    Gamberini, Maria R.
    Lisi, Roberto
    D'Ascola, Domenico G.
    Rosso, Rosamaria
    Allo, Massimo
    Spasiano, Anna
    Restaino, Gennaro
    Righi, Riccardo
    Mangione, Maurizio
    Positano, Vincenzo
    Ricchi, Paolo
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (05) : 783 - 795
  • [23] SUCCESSFUL TREATMENT OF "HARD-TO-CHELATE" β-THALASSAEMIA MAJOR PATIENTS WITH DAILY ALTERNATING DEFERASIROX AND DEFERIPRONE
    Pinto, V.
    Balocco, M.
    Quintino, S.
    Lamagna, M.
    Carrara, P.
    Forni, G. L.
    HAEMATOLOGICA, 2015, 100 : 15 - 15
  • [24] The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients
    Allegra, Sarah
    Cusato, Jessica
    De Francia, Silvia
    Longo, Filomena
    Pirro, Elisa
    Massano, Davide
    Avataneo, Valeria
    De Nicolo, Amedeo
    Piga, Antonio
    D'Avolio, Antonio
    PHARMACOGENOMICS JOURNAL, 2019, 19 (05): : 417 - 427
  • [25] Deferasirox in Indian children with thalassemia major: 3 years experience
    Dhamija, Mayank
    Mahajan, Amita
    Kalra, Manas
    Virmani, Anju
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2013, 34 (01) : 16 - 20
  • [26] Impaired oxygen kinetics in beta-thalassaemia major patients
    Vasileiadis, I.
    Roditis, P.
    Dimopoulos, S.
    Ladis, V.
    Pangalis, G.
    Aessopos, A.
    Nanas, S.
    ACTA PHYSIOLOGICA, 2009, 196 (03) : 357 - 363
  • [27] Efficacy and Tolerability of Twice-Daily Dosing Schedule of Deferasirox in Transfusion-Dependent Paediatric Beta-Thalassaemia Patients: A Randomized Controlled Study
    Panachiyil, George Mathew
    Babu, Tirin
    Sebastian, Juny
    Ravi, Mandyam Dhati
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 749 - 755
  • [28] Clinical experience with growth hormone treatment in patients with β-thalassaemia major
    De Sanctis, V
    Urso, L
    BIODRUGS, 1999, 11 (02) : 79 - 85
  • [29] Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience
    Vlachaki Efthimia
    Nikolaos Neokleous
    Alexandra Agapidou
    Marina Economou
    Evaggelia Vetsiou
    Aikaterini Teli
    Vasileios Perifanis
    Annals of Hematology, 2013, 92 : 263 - 265
  • [30] Clinical experience with growth hormone treatment in patients with β- thalassaemia major
    De Sanctis V.
    Urso L.
    BioDrugs, 1999, 11 (2) : 79 - 85
12345